| Trial ID: | L0088 |
| Source ID: | NCT04704063
|
| Associated Drug: |
Tocotrienols
|
| Title: |
Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)
|
| Acronym: |
T3-NAFL
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Hepatic Steatosis|NAFLD
|
| Interventions: |
Drug: Tocotrienols / Vitamin E|Drug: Placebo control
|
| Outcome Measures: |
Reduction of Liver Fat (VLFF)|Change in liver biochemistry|Change in liver fat fraction|Change in serum lipid profile|Occurrence of adverse events and serious adverse events
|
| Sponsor/Collaborators: |
Yuen Kah Hay|Monash University Malaysia|Hovid Berhad|Universiti Sains Malaysia
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
170
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
January 1, 2021
|
| Completion Date: |
June 1, 2023
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 6, 2021
|
| Locations: |
KK Bandar Baru Air Itam, Air Itam, Penang, Malaysia|KK Bayan Baru, Bayan Baru, Penang, Malaysia|Hospital Seberang Jaya (CRC), Seberang Jaya, Penang, Malaysia|KK Jalan Perak, Penang, Malaysia
|
| URL: |
https://ClinicalTrials.gov/show/NCT04704063
|
